Treato

About:

Treato collects patient-written health experiences from blogs and forums, offering real-time insights into patients’ opinions and attitudes.

Website: https://treato.com

Twitter/X: Treato_Com

Top Investors: OrbiMed, Western Technology Investment, New Leaf Venture Partners, REV, Shmuel Cabilly

Description:

Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions. Treato's big data analytics are available in a consumer site and as an in-depth service for pharmaceutical marketers. Treato's Consumer site ([treato.com](http://treato.com)) provides an indispensible patient-oriented knowledge source which is completely advertising-free and free-of-charge, visited by hundreds of thousands of users each week. [Treato Pharma](http://treato.com/pharma) is an innovative brand intelligence service for pharmaceutical marketers and agencies that provides real-time insights into patients’ opinions and attitudes, enabling them to understand competitive positioning, determine DTC priorities, and enhance patient engagement.

Total Funding Amount:

$14.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Or Yehuda, Tel Aviv, Israel

Founded Date:

2008-10-01

Contact Email:

info(AT)treato.com

Founders:

Gideon Mantel

Number of Employees:

11-50

Last Funding Date:

2013-04-23

IPO Status:

Private

© 2024 MyAiNote.com